Xiamen Eye Center
Welcome,         Profile    Billing    Logout  
 4 Trials 
11 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Wei, Li
NCT06747455: BCG for Therapeutic Use Phase Ⅲ Clinical Trial

Not yet recruiting
3
438
RoW
BCG for Therapeutic Use, BCG for Therapeutic Use ( BI SAI JI )
Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd.
BCG
10/28
12/28
NCT06588335: BTLA Inhibitor (JS004) Combined with Toripalimab and Chemotherapy in the Perioperative Treatment of Resectable Locally Advanced Thoracic Esophageal Squamous Cell Carcinoma

Not yet recruiting
2
20
NA
BTLA inhibitor (JS004), Toripalimab, Paclitaxel, Cisplatin
Henan Provincial People's Hospital
Esophageal Squamous Cell Carcinoma
09/25
09/26
NCT04661956: The Diagnostic Yield and Safety of Transbronchial Cryobiopsy in The Pulmonary Periphral Nodule

Recruiting
N/A
300
RoW
Transbronchial cryobiopsy/Transbronchial lung biopsy (forcep)
ShiYue Li
Diagnosis, Complication Rate
06/22
06/22
NCT05442346: Safety and Efficacy Evaluation of γ-globin Reactivated Autologous Hematopoietic Stem Cells

Suspended
N/A
5
RoW
γ-globin reactivated autologous hematopoietic stem cells
Bioray Laboratories, First Affiliated Hospital of Guangxi Medical University
Thalassemia Major
09/24
11/24
SPEED, NCT06862206: This is a Non-interventional, Study to Assess Demographic Characteristics and Patient Reported Outcomes in China Patients With SEA Treated With Benralizumab

Not yet recruiting
N/A
1000
RoW
benralizumab
AstraZeneca
Chronic Obstructive Pulmonary Disease
01/26
01/26
NCT04830826: A Real-world Study of Adjuvant Therapy in Early Stage NSCLC With EGFR Mutation-Positive in China

Recruiting
N/A
2000
RoW
Surgeries
The First Affiliated Hospital of Guangzhou Medical University
NSCLC, Stage I, NSCLC, Stage II, NSCLC, Stage III
01/24
07/24
Liu, Zuguo
NCT04633213: A Study Evaluating HBM9036 Efficacy and Safety on Moderate to Severe Dry Eye

Recruiting
3
674
RoW
HBM9036 0.25% Ophthalmic Solution, Placebo
Harbour BioMed (Guangzhou) Co. Ltd.
Dry Eye
12/22
04/23
NCT05629390: Trial to Evaluate the Efficacy and Safety of TP-03, LIBRA Study

Completed
3
163
RoW
Lotilaner, TP-03, S-Misoxam, Vehicle Control
LianBio LLC
Blepharitis
09/23
04/24
NCT06717152: Efficacy and Safety of SJP-0132 Eye Drops in Chinese Patients With Dry Eye Disease

Recruiting
3
400
RoW
SJP-0132, Placebo
Senju Pharmaceutical Science & Technology (Beijing) Co., Ltd., Senju Pharmaceutical Co., Ltd.
Dry Eye
07/25
08/25
ZKO-CSP-CSA-302, NCT06766357: A Study of the Efficacy and Safety of Cyclosporin Ophthalmic Gel in Subjects with Moderate to Severe Dry Eye Disease

Not yet recruiting
3
360
RoW
Cyclosporine ophthalmic gel, Cyclosporine, Cyclosporine ophthalmic gel vehicle, Vehicle
Zhaoke (Guangzhou) Ophthalmology Pharmaceutical Ltd.
Moderate to Severe Dry Eye
02/26
06/26
NCT06133166: A Study for the Treatment of Dry Eye in Postmenopausal Women

Recruiting
2
240
RoW
EG017 ointment, EG017 ointment placebo
Changchun GeneScience Pharmaceutical Co., Ltd.
Postmenopausal Women With DED
05/24
08/24
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Wei, Li
NCT06747455: BCG for Therapeutic Use Phase Ⅲ Clinical Trial

Not yet recruiting
3
438
RoW
BCG for Therapeutic Use, BCG for Therapeutic Use ( BI SAI JI )
Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd.
BCG
10/28
12/28
NCT06588335: BTLA Inhibitor (JS004) Combined with Toripalimab and Chemotherapy in the Perioperative Treatment of Resectable Locally Advanced Thoracic Esophageal Squamous Cell Carcinoma

Not yet recruiting
2
20
NA
BTLA inhibitor (JS004), Toripalimab, Paclitaxel, Cisplatin
Henan Provincial People's Hospital
Esophageal Squamous Cell Carcinoma
09/25
09/26
NCT04661956: The Diagnostic Yield and Safety of Transbronchial Cryobiopsy in The Pulmonary Periphral Nodule

Recruiting
N/A
300
RoW
Transbronchial cryobiopsy/Transbronchial lung biopsy (forcep)
ShiYue Li
Diagnosis, Complication Rate
06/22
06/22
NCT05442346: Safety and Efficacy Evaluation of γ-globin Reactivated Autologous Hematopoietic Stem Cells

Suspended
N/A
5
RoW
γ-globin reactivated autologous hematopoietic stem cells
Bioray Laboratories, First Affiliated Hospital of Guangxi Medical University
Thalassemia Major
09/24
11/24
SPEED, NCT06862206: This is a Non-interventional, Study to Assess Demographic Characteristics and Patient Reported Outcomes in China Patients With SEA Treated With Benralizumab

Not yet recruiting
N/A
1000
RoW
benralizumab
AstraZeneca
Chronic Obstructive Pulmonary Disease
01/26
01/26
NCT04830826: A Real-world Study of Adjuvant Therapy in Early Stage NSCLC With EGFR Mutation-Positive in China

Recruiting
N/A
2000
RoW
Surgeries
The First Affiliated Hospital of Guangzhou Medical University
NSCLC, Stage I, NSCLC, Stage II, NSCLC, Stage III
01/24
07/24
Liu, Zuguo
NCT04633213: A Study Evaluating HBM9036 Efficacy and Safety on Moderate to Severe Dry Eye

Recruiting
3
674
RoW
HBM9036 0.25% Ophthalmic Solution, Placebo
Harbour BioMed (Guangzhou) Co. Ltd.
Dry Eye
12/22
04/23
NCT05629390: Trial to Evaluate the Efficacy and Safety of TP-03, LIBRA Study

Completed
3
163
RoW
Lotilaner, TP-03, S-Misoxam, Vehicle Control
LianBio LLC
Blepharitis
09/23
04/24
NCT06717152: Efficacy and Safety of SJP-0132 Eye Drops in Chinese Patients With Dry Eye Disease

Recruiting
3
400
RoW
SJP-0132, Placebo
Senju Pharmaceutical Science & Technology (Beijing) Co., Ltd., Senju Pharmaceutical Co., Ltd.
Dry Eye
07/25
08/25
ZKO-CSP-CSA-302, NCT06766357: A Study of the Efficacy and Safety of Cyclosporin Ophthalmic Gel in Subjects with Moderate to Severe Dry Eye Disease

Not yet recruiting
3
360
RoW
Cyclosporine ophthalmic gel, Cyclosporine, Cyclosporine ophthalmic gel vehicle, Vehicle
Zhaoke (Guangzhou) Ophthalmology Pharmaceutical Ltd.
Moderate to Severe Dry Eye
02/26
06/26
NCT06133166: A Study for the Treatment of Dry Eye in Postmenopausal Women

Recruiting
2
240
RoW
EG017 ointment, EG017 ointment placebo
Changchun GeneScience Pharmaceutical Co., Ltd.
Postmenopausal Women With DED
05/24
08/24

Download Options